Show source-provided references
4. Dithmer, S., Blasig, I.E., Fraser, P.A., Qin, Z., and Haseloff, R.F. (2024). The Basic Requirement of Tight Junction Proteins in Blood-Brain Barrier Function and Their Role in Pathologies. Int. J. Mol. Sci., 25.
10.3390/ijms25115601 ↗10. Ultrasound-mediated blood-brain barrier opening: An effective drug delivery system for theranostics of brain diseases
10.1016/j.addr.2022.114539 ↗11. Kim, J., Shin, S.A., Lee, C.S., and Chung, H.J. (2023). An Improved In Vitro Blood-Brain Barrier Model for the Evaluation of Drug Permeability Using Transwell with Shear Stress. Pharmaceutics, 16.
10.3390/pharmaceutics16010048 ↗12. Stone, N.L., England, T.J., and O’Sullivan, S.E. (2019). A Novel Transwell Blood Brain Barrier Model Using Primary Human Cells. Front. Cell Neurosci., 13.
10.3389/fncel.2019.00230 ↗13. Developing a transwell millifluidic device for studying blood-brain barrier endothelium
10.1039/D2LC00657J ↗14. In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use
10.1177/0271678X16630991 ↗16. Pericytes repair engineered defects in the basement membrane to restore barrier integrity in an in vitro model of the blood-brain barrier
10.1016/j.mtbio.2025.102361 ↗17. Alkhalifa, A.E., Al-Ghraiybah, N.F., Odum, J., Shunnarah, J.G., Austin, N., and Kaddoumi, A. (2023). Blood-Brain Barrier Breakdown in Alzheimer’s Disease: Mechanisms and Targeted Strategies. Int. J. Mol. Sci., 24.
10.3390/ijms242216288 ↗18. O’Halloran, L., Akinsete, O., Kogan, A.L., Wrona, M., and Mahdi, A.F. (2025). 3D in vitro blood-brain barrier models: Recent advances and their role in brain disease research and therapy. Front. Pharmacol., 16.
10.3389/fphar.2025.1637602 ↗20. Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood-Brain Barrier and Glioblastoma
10.1002/smll.202302280 ↗21. Development of a 3D-3 co-culture microbead consisting of cancer-associated fibroblasts and human umbilical vein endothelial cells for the anti-tumor drug assessment of lung cancer
10.21037/tlcr-2025-525 ↗22. Modeling antithymocyte globulin-induced microvasculopathy using human iPSC-derived vascularized liver organoids
10.1016/j.xcrm.2025.102433 ↗23. Three-Dimensional Dynamic Blood-Brain Barrier Model Incorporating Native Cell Culture Systems Based on Shape Memory Biomaterials
10.1002/adhm.202500066 ↗24. Engineered liver-derived decellularized extracellular matrix-based three-dimensional tumor constructs for enhanced drug screening efficiency
10.1093/rb/rbae113 ↗27. Human Placenta Decellularized Extracellular Matrix Hydrogel Promotes the Generation of Human Spinal Cord Organoids with Dorsoventral Organization from Human Induced Pluripotent Stem Cells
10.1021/acsbiomaterials.4c00067 ↗29. The “Big Three” in biocompatibility testing of medical devices: Implementation of alternatives to animal experimentation-are we there yet?
10.3389/ftox.2023.1337468 ↗30. Biotransformation method for corneal tissue engineering: In vitro study of the fabrication and characterization of a decellularized hydrogel from salmon skin extracellular matrix
10.1016/j.ijbiomac.2025.145373 ↗32. Liu, L., Pang, Y., Yang, H., Zhou, Q., Hou, J., Wu, W., and Elango, J. (2025). Squid Skin Decellularised Dermal Matrix for Enhancing Repair of Acute Cranial Injuries in Rabbit Model. J. Funct. Biomater., 16.
10.3390/jfb16050159 ↗34. Endothelial delivery of simvastatin by LRP1-targeted nanoparticles ameliorates pathogenesis of alzheimer’s disease in a mouse model
10.1186/s13195-025-01840-5 ↗36. The development of marine biomaterial derived from decellularized squid mantle for potential application as tissue engineered urinary conduit
10.1016/j.msec.2020.111579 ↗37. Liberale, L., Bertolotto, M., Minetti, S., Contini, P., Verzola, D., Ameri, P., Ghigliotti, G., Pende, A., Camici, G.G., and Carbone, F. (2020). Recombinant Tissue Plasminogen Activator (r-tPA) Induces In-Vitro Human Neutrophil Migration via Low Density Lipoprotein Receptor-Related Protein 1 (LRP-1). Int. J. Mol. Sci., 21.
10.3390/ijms21197014 ↗39. Decellularized squid mantle scaffolds as tissue-engineered corneal stroma for promoting corneal regeneration
10.1002/btm2.10531 ↗40. Novel Decellularization Scheme for Preparing Acellular Fish Scale Scaffolds for Bone Tissue Engineering
10.1021/acsomega.4c05096 ↗42. Fast, robust and effective decellularization of whole human livers using mild detergents and pressure controlled perfusion
10.1016/j.msec.2019.110200 ↗43. Monitoring decellularization via absorbance spectroscopy during the derivation of extracellular matrix scaffolds
44. Nondestructive assessment of tissue engineered cartilage based on biochemical markers in cell culture media: Application of attenuated total reflection Fourier transform infrared (ATR-FTIR) spectroscopy
10.1039/D1AN02351A ↗45. Attenuated Total Reflection Fourier Transform Infrared (ATR FT-IR) Spectroscopy as an Analytical Method to Investigate the Secondary Structure of a Model Protein Embedded in Solid Lipid Matrices
10.1177/0003702817739908 ↗47. The effect of terminal sterilization on structural and biophysical properties of a decellularized collagen-based scaffold; implications for stem cell adhesion
10.1002/jbm.b.33213 ↗48. Rohde, F., Danz, K., Jung, N., Wagner, S., and Windbergs, M. (2022). Electrospun Scaffolds as Cell Culture Substrates for the Cultivation of an In Vitro Blood-Brain Barrier Model Using Human Induced Pluripotent Stem Cells. Pharmaceutics, 14.
10.3390/pharmaceutics14061308 ↗50. Diao, X., Han, H., Sun, H., Zhang, H., and Wu, W. (2024). Protection of Tight Junctional Complexes between hCMEC/D3 Cells by Deep-Sea Fibrinolytic Compound FGFC1. Mar. Drugs, 22.
10.3390/md22080341 ↗51. Microfiber-Templated Porogel Bioinks Enable Tubular Interfaces and Microvascularization Down to the Building Blocks for 3D Bioprinting
10.1002/smll.202501594 ↗52. A biomimetic orthogonal-bilayer tubular scaffold for the co-culture of endothelial cells and smooth muscle cells
10.1039/D1RA04472A ↗53. Characterization of Native Extracellular Matrix of Patient-Derived Glioblastoma Multiforme Organoids
54. Biomimetic Scaffolds Enhance iPSC Astrocyte Progenitor Angiogenic, Immunomodulatory, and Neurotrophic Capacity in a Stiffness and Matrix-Dependent Manner for Spinal Cord Repair Applications
10.1002/adhm.202500830 ↗55. Osteoinduction and proliferation of bone-marrow stromal cells in three-dimensional poly (epsilon-caprolactone)/ hydroxyapatite/collagen scaffolds
10.1186/s12967-015-0499-8 ↗56. Deciphering pericyte-induced temozolomide resistance in glioblastoma with a 3D microphysiological system mimicking the biomechanical properties of brain tissue
10.1016/j.actbio.2025.05.038 ↗57. Lochhead, J.J., Yang, J., Ronaldson, P.T., and Davis, T.P. (2020). Structure, Function, and Regulation of the Blood-Brain Barrier Tight Junction in Central Nervous System Disorders. Front. Physiol., 11.
10.3389/fphys.2020.00914 ↗60. Ohbuchi, M., Shibuta, M., Tetsuka, K., Sasaki-Iwaoka, H., Oishi, M., Shimizu, F., and Nagasaka, Y. (2024). Modeling of Blood-Brain Barrier (BBB) Dysfunction and Immune Cell Migration Using Human BBB-on-a-Chip for Drug Discovery Research. Int. J. Mol. Sci., 25.
10.3390/ijms25126496 ↗61. 3D brain angiogenesis model to reconstitute functional human blood-brain barrier in vitro
10.1002/bit.27224 ↗62. Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model
10.1074/jbc.M111.225532 ↗63. Faissner, A. (2023). Low-density lipoprotein receptor-related protein-1 (LRP1) in the glial lineage modulates neuronal excitability. Front. Netw. Physiol., 3.
10.3389/fnetp.2023.1190240 ↗64. Chinese medicine Tongxinluo capsule protects against blood-brain barrier disruption after ischemic stroke by inhibiting the low-density lipoprotein receptor-related protein 1 pathway in mice
10.1016/j.jstrokecerebrovasdis.2020.105071 ↗65. Endothelial Dysfunctions in Blood-Brain Barrier Breakdown in Alzheimer’s Disease: From Mechanisms to Potential Therapies
10.1111/cns.70079 ↗66. An apolipoprotein E receptor mimetic peptide decreases blood-brain barrier permeability following intracerebral hemorrhage by inhibiting the CypA/MMP-9 signaling pathway via LRP1 activation
10.1016/j.intimp.2024.113007 ↗67. Bres, E.E., and Faissner, A. (2019). Low Density Receptor-Related Protein 1 Interactions With the Extracellular Matrix: More Than Meets the Eye. Front. Cell Dev. Biol., 7.
10.3389/fcell.2019.00031 ↗69. Mechanisms of high-density lipoprotein in regulating blood-brain barrier function: Insights and implications
10.1186/s12987-025-00721-1 ↗71. Identification of a potent indigoid persister antimicrobial by screening dormant cells
10.1002/bit.27078 ↗73. BBB on chip: Microfluidic platform to mechanically and biochemically modulate blood-brain barrier function
10.1007/s10544-012-9699-7 ↗74. Astrocytic LRP1 enables mitochondria transfer to neurons and mitigates brain ischemic stroke by suppressing ARF1 lactylation
10.1016/j.cmet.2024.05.016 ↗75. Low-density lipoprotein receptor-related protein-1 facilitates heme scavenging after intracerebral hemorrhage in mice
10.1177/0271678X16654494 ↗76. TLR7 (Toll-Like Receptor 7) Facilitates Heme Scavenging Through the BTK (Bruton Tyrosine Kinase)-CRT (Calreticulin)-LRP1 (Low-Density Lipoprotein Receptor-Related Protein-1)-Hx (Hemopexin) Pathway in Murine Intracerebral Hemorrhage
10.1161/STROKEAHA.118.022155 ↗77. Tissue plasminogen activator expression and barrier properties of human brain microvascular endothelial cells
10.1159/000335785 ↗80. The role of the low-density lipoprotein receptor–related protein 1 (LRP-1) in regulating blood-brain barrier integrity
82. Codispoti, G., Carniato, M., Brogini, S., Romanelli, A., Martini, L., Giavaresi, G., and Tschon, M. (2024). Decellularized biological matrices for the repair of rotator cuff lesions: A systematic review of preclinical in vivo studies. Front. Bioeng. Biotechnol., 12.
10.3389/fbioe.2024.1345343 ↗